These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

732 related items for PubMed ID: 9631111

  • 1. A randomised crossover comparison of reserpine and sustained-release nifedipine in hypertension.
    Manyemba J.
    Cent Afr J Med; 1997 Dec; 43(12):344-9. PubMed ID: 9631111
    [Abstract] [Full Text] [Related]

  • 2. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
    Misra KP, Joglekar SJ, Mukherjee S, Nanivadekar AS.
    J Assoc Physicians India; 1998 Dec; Suppl 1():30-40. PubMed ID: 11233385
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y.
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [Abstract] [Full Text] [Related]

  • 4. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F.
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [Abstract] [Full Text] [Related]

  • 5. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S, Caglar N, Canberk A, Deger N, Demirtas M, Dortlemez H, Kiliccioglu B, Kozan O, Ovunc K, Turkoglu C.
    Curr Med Res Opin; 2003 Sep; 19(3):226-37. PubMed ID: 12803737
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Perindopril plus nifedipine versus perindopril plus hydrochlorothiazide in mild to severe hypertension: a double-blind multicentre study. The Multicentre Study Group on Treatment Association with Perindopril.
    Letellier P, Overlack A, Agnes E, Desche P.
    J Hum Hypertens; 1994 Feb; 8(2):145-9. PubMed ID: 8207741
    [Abstract] [Full Text] [Related]

  • 8. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A.
    Blood Press Suppl; 1995 Feb; 3():38-46. PubMed ID: 8535541
    [Abstract] [Full Text] [Related]

  • 9. Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation.
    Fogari R, Preti P, Zoppi A, Corradi L, Pasotti C, Rinaldi A, Mugellini A.
    Am J Hypertens; 2005 May; 18(5 Pt 1):577-83. PubMed ID: 15882537
    [Abstract] [Full Text] [Related]

  • 10. A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension.
    Pareek A, Basavanagowdappa H, Zawar S, Kumar A, Chandurkar N.
    Expert Opin Pharmacother; 2009 Jul; 10(10):1529-36. PubMed ID: 19514864
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive efficacy of indapamide SR in hypertensive patients uncontrolled with a background therapy: the NATIVE study.
    Akram J, Sheikh UE, Mahmood M, Donnelly R.
    Curr Med Res Opin; 2007 Dec; 23(12):2929-36. PubMed ID: 17931463
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of cilazapril and nifedipine retard on ambulatory blood pressure, metabolic, rheological and platelet function in hypertensive patients.
    Ding YA, Law HW, Chou TC.
    J Hum Hypertens; 1994 Feb; 8(2):137-43. PubMed ID: 8207740
    [Abstract] [Full Text] [Related]

  • 15. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 16. Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT).
    Brown MJ, Castaigne A, de Leeuw PW, Mancia G, Rosenthal T, Ruilope LM.
    J Hypertens; 1998 Dec; 16(12 Pt 2):2113-6. PubMed ID: 9886905
    [Abstract] [Full Text] [Related]

  • 17. Combination of a thiazide, a vasodilator and reserpine compared with methyldopa plus hydrochlorothiazide in the treatment of hypertension in Zimbabwe.
    Stein CM, Neill P, Mwaluko GM, Kusema T.
    S Afr Med J; 1990 Mar 03; 77(5):243-5. PubMed ID: 2107581
    [Abstract] [Full Text] [Related]

  • 18. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P.
    J Hypertens; 1998 Nov 03; 16(11):1357-69. PubMed ID: 9856375
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA, Rizzoni D, DIMS II (Delapril-Indapamide Multicenter Study II).
    J Hum Hypertens; 2003 Feb 03; 17(2):139-46. PubMed ID: 12574793
    [Abstract] [Full Text] [Related]

  • 20. [Antihypertensive first-line and add-on treatment with a fixed controlled release combination of metoprololsuccinate/hydrochlorothiazide. Prospective doctor's office observational study in 14,964 patients].
    Hildemann SK, Fischer HM, Pittrow D, Bohlscheid V.
    Fortschr Med Orig; 2003 Feb 03; 121(1):27-32. PubMed ID: 15117066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.